Get started
Zai Lab Ltd. Sponsored ADRZai Lab Ltd. Sponsored ADRZai Lab Ltd. Sponsored ADR

Zai Lab Ltd. Sponsored ADR

No trades
See on Supercharts
OverviewFinancialsNewsDiscussionsTechnicalsForecastSeasonalsOptionsETFs

ZLAB chart


Full chart

ZLAB upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.77 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.05 USD
Net income (FY)
‪−257.23 M‬ USD
Revenue (FY)
‪399.19 M‬ USD
Shares float
‪108.95 M‬
Beta (1Y)
0.67

About Zai Lab Ltd.


Sector
Health Technology
Industry
Biotechnology
CEO
Ying Du
Website
zailaboratory.com
Headquarters
Shanghai
Founded
2014
ISIN
US98887Q1040
FIGI
BBG00HFX3N90
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.

Check out other big names from the same industry as ZLAB.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ZLAB news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs with ZLAB exposure


IBB
iShares Biotechnology ETF
Weight
0.24%
Market value
‪15.00 M‬
USD
FCSI
Franklin ClearBridge International Growth Fund
Weight
1.14%
Market value
‪2.85 M‬
USD
2820
Global X China Biotech ETF
Weight
2.39%
Market value
‪2.21 M‬
USD
CANC
Tema Oncology ETF
Weight
2.50%
Market value
‪2.07 M‬
USD
SBIO
ALPS Medical Breakthroughs ETF
Weight
1.82%
Market value
‪1.73 M‬
USD
CGNG
Capital Group New Geography Equity ETF
Weight
0.17%
Market value
‪1.58 M‬
USD
371470
MIRAE ASSET TIGER CHINA BIOTECH SOLACTIVE ETF
Weight
2.10%
Market value
‪1.32 M‬
USD
PGJ
Invesco Golden Dragon China ETF
Weight
0.74%
Market value
‪1.21 M‬
USD
BTEC
iShares NASDAQ US Biotechnology UCITS ETF
Weight
0.14%
Market value
‪929.95 K‬
USD
BTEE
iShares NASDAQ US Biotechnology UCITS ETF
Weight
0.14%
Market value
‪929.95 K‬
USD
FMED
Fidelity Disruptive Medicine ETF
Weight
1.36%
Market value
‪779.05 K‬
USD

Explore more ETFs